<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK OnDemand

For Medtech Advisors, Consultants or Financial Services Providers

SmartTRAK is the most comprehensive and up-to-date market intelligence platform providing all the info you need in one place for crucial decision making. You can quickly get access to market, financial, product and competitive data along with interactive tools and dashboards that will help you maximize your project ROI.

We offer flexible contracting along with optional add-on industry analyst consultative support.

Strategic Analysis

  • Market Shares & Sizing
  • Partnerships & Alliances
  • Growth Rates
  • Competitive Landscape Assessments
  • Exit Strategy
  • Regulatory

Financial Analysis

  • Historic Revenues
  • Quarterly Financial Reviews
  • Market & Company Revenues & Market Caps
  • M&A Transaction History

Data Analysis

  • Procedure Volumes and Trends for US and Global
  • Brands and Pricing Analytics
  • Treatments by Site of Care (Wound Care)

Daily Market Updates

  • New M&A Activity
  • Industry Trends
  • Product Launches
  • Recalls
  • …and more

SmartTRAK
Medtech
Markets Covered

2 (7)

 

Orthopedics

Ortho Site of Care

Enabling Technologies

Injectables

Extremities

OrthoBio

Spine

Soft Tissue Fixation

Visualization

Total Joints

Trauma

Wound Care

Advanced Wound Care

Conventional Wound Care

Surgical Matrices

Regenerative Medicine

Amniotic Tissue

Cell Processing

Neuro Therapies

Neurovascular

Neuromodulation

Medtech News & Analysis

Recent blog posts
Wound Care

Exosomes in Wound Care: The Next Big Thing?

SmartTRAK interviews Suneet Varma, CEO of INTENT Biologics, to discuss the company’s novel exosome techn...

Orthobiologics

NASS Biologic Interventions 2025: Spotlight on Theradaptive

Theradaptive’s Chief Scientific Officer Frank Vizesi provides an overview of the company’s unique protei...

Wound Care

Tempo Therapeutics: Start-Up Spotlight

SmartTRAK spoke with the Westbrook Weaver, CEO of Tempo Therapeutics, to discuss the company’s new techn...